Although oncologists identified patient- and disease-level factors that complicated the decision to omit SLNB in women 70 years and older with HR-positive, ERBB2-negative breast cancer, the themes regarding the importance of patient preference and physiological age could be addressed with interventions to improve patient-physician communication. The gene discussed is ERBB2; the disease is breast cancer.